Clinical Trial Update: Shingrix in Renal Transplant Recipients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate the Shingrix vaccine in kidney transplant recipients to assess response and protection against herpes zoster.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Kidney Transplant Recipient Response to Shingrix Vaccine, Kidney Failure | Phase 3 | Status: RECRUITING